Before you do, I want to acknowledge the work of the MS Society and of Mr. Savoie.
While health care is provincial, the federal government has some responsibility involving aboriginal health and the armed forces, and I think the discussion of CCSVI is relevant to the entire country.
I am concerned that the MS Society is not aware of the International Union of Phlebology and its consensus document on the diagnosis and treatment of venous malformations. Data out of Buffalo shows that about 52% of MS patients show CCSVI. The initial data shows treatment relieves brain fuzziness and improves quality of life. Should we not be advocating for anything that improves quality of life? If we look at injections such as Copaxone and interferon, which cost $25,000 a year, do we see the results that we have seen with this initial work?